Join the Duragesic group to help and get support from people like you.
Duragesic News (Page 3)
FDA Medwatch Alert: Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure
[Posted 09/23/2013] ISSUE: FDA is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily. FDA continues to learn of deaths from accidental...
FDA Medwatch Alert: Transdermal Drug Patches with Metallic Backings: Risk of Burns during MRI Scans
[Posted 03/05/2009] FDA notified healthcare professionals and patients that certain transdermal patches (medicated patches applied to the skin), containing aluminum or other metals in the backing of...
FDA Medwatch Alert: Duragesic (fentanyl transdermal system) - Jul 8, 2005
[Posted 07/08/2005] Janssen and FDA notified healthcare professionals of changes to the BOXED WARNING/WARNINGS, CONTRAINDICATIONS, PRECAUTIONS, and DOSAGE AND ADMINISTRATION sections of the...
FDA Medwatch Alert: Duragesic (fentanyl transdermal system) - Feb 20, 2004
(February 20, 2004) Janssen Pharmaceutica and FDA notified healthcare professionals of a Class I recall of DURAGESIC 75 mcg/h. Only Control Number 0327192 (expiration October 2005) is subject to this...